BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11378093)

  • 1. Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain.
    Yoshimura N; Seki S; Erickson V; Erickson K; Kassotakis L; Novakovic S; Fraser MO; Chancellor MB; de Groat WC
    Urology; 2001 Jun; 57(6 Suppl 1):116-7. PubMed ID: 11378093
    [No Abstract]   [Full Text] [Related]  

  • 2. The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain.
    Yoshimura N; Seki S; Novakovic SD; Tzoumaka E; Erickson VL; Erickson KA; Chancellor MB; de Groat WC
    J Neurosci; 2001 Nov; 21(21):8690-6. PubMed ID: 11606657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons.
    Lai J; Hunter JC; Ossipov MH; Porreca F
    Methods Enzymol; 2000; 314():201-13. PubMed ID: 10565014
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrodotoxin-resistant sodium channels Na(v)1.8/SNS and Na(v)1.9/NaN in afferent neurons innervating urinary bladder in control and spinal cord injured rats.
    Black JA; Cummins TR; Yoshimura N; de Groat WC; Waxman SG
    Brain Res; 2003 Feb; 963(1-2):132-8. PubMed ID: 12560118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain.
    Porreca F; Lai J; Bian D; Wegert S; Ossipov MH; Eglen RM; Kassotakis L; Novakovic S; Rabert DK; Sangameswaran L; Hunter JC
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7640-4. PubMed ID: 10393873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single serine residue confers tetrodotoxin insensitivity on the rat sensory-neuron-specific sodium channel SNS.
    Sivilotti L; Okuse K; Akopian AN; Moss S; Wood JN
    FEBS Lett; 1997 Jun; 409(1):49-52. PubMed ID: 9199502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction.
    Ritter AM; Martin WJ; Thorneloe KS
    Neurosci Lett; 2009 Mar; 452(1):28-32. PubMed ID: 19146922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome.
    Yoshimura N; Seki S; Chancellor MB; de Groat WC; Ueda T
    Urology; 2002 May; 59(5 Suppl 1):61-7. PubMed ID: 12007524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a model of chronic orofacial hyperalgesia in the rat: contribution of NA(V) 1.8.
    Morgan JR; Gebhart GF
    J Pain; 2008 Jun; 9(6):522-31. PubMed ID: 18337185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE).
    Yoshimura N; Franks ME; Sasaki K; Goins WF; Goss J; Yokoyama T; Fraser MO; Seki S; Fink J; Glorioso J; de Groat WC; Chancellor MB
    Urology; 2001 Jun; 57(6 Suppl 1):116. PubMed ID: 11378092
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular cloning of a putative tetrodotoxin-resistant sodium channel from dog nodose ganglion neurons.
    Chen J; Ikeda SR; Lang W; Isales CM; Wei X
    Gene; 1997 Nov; 202(1-2):7-14. PubMed ID: 9427539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons.
    Dib-Hajj SD; Tyrrell L; Cummins TR; Black JA; Wood PM; Waxman SG
    FEBS Lett; 1999 Nov; 462(1-2):117-20. PubMed ID: 10580103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
    Zhou X; Dong XW; Crona J; Maguire M; Priestley T
    J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways.
    Akopian AN; Souslova V; England S; Okuse K; Ogata N; Ure J; Smith A; Kerr BJ; McMahon SB; Boyce S; Hill R; Stanfa LC; Dickenson AH; Wood JN
    Nat Neurosci; 1999 Jun; 2(6):541-8. PubMed ID: 10448219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
    Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesia.
    Moon JY; Song S; Yoon SY; Roh DH; Kang SY; Park JH; Beitz AJ; Lee JH
    Anesth Analg; 2012 Jan; 114(1):215-23. PubMed ID: 22127815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves.
    Yiangou Y; Birch R; Sangameswaran L; Eglen R; Anand P
    FEBS Lett; 2000 Feb; 467(2-3):249-52. PubMed ID: 10675548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed rats.
    Coggeshall RE; Tate S; Carlton SM
    Neurosci Lett; 2004 Jan; 355(1-2):45-8. PubMed ID: 14729231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of Nav1.8 by small molecules.
    Krafte DS; Chapman M; Marron B; Atkinson R; Liu Y; Ye F; Curran M; Kort M; Jarvis MF
    Channels (Austin); 2007; 1(3):152-3. PubMed ID: 18690030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells.
    Dekker LV; Daniels Z; Hick C; Elsegood K; Bowden S; Szestak T; Burley JR; Southan A; Cronk D; James IF
    Eur J Pharmacol; 2005 Dec; 528(1-3):52-8. PubMed ID: 16325806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.